DF
EW icon

Dunhill Financial’s Edwards Lifesciences EW Stock Holding History

Dunhill Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$826 Sell
10
-10
-50% -$824 ﹤0.01% 1004
2025
Q4 		$1.71K Buy
20
+7
+54% +$574 ﹤0.01% 768
2025
Q3 		$1K Sell
13
-7
-35% -$547 ﹤0.01% 772
2025
Q2 		$1.59K Sell
20
-123
-86% -$9.17K ﹤0.01% 720
2025
Q1 		$10.3K Sell
143
-10
-7% -$716 ﹤0.01% 407
2024
Q4 		$11.3K Buy
153
+30
+24% +$2.1K 0.01% 353
2024
Q3 		$8.11K Buy
123
+65
+112% +$4.72K ﹤0.01% 439
2024
Q2 		$5.4K Buy
58
+11
+23% +$974 ﹤0.01% 385
2024
Q1 		$4.45K Buy
47
+8
+21% +$672 ﹤0.01% 335
2023
Q4 		$2.99K Buy
+39
New +$2.71K ﹤0.01% 378

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Dunhill Financial's EW Position: Q1 2026 in Review

Dunhill Financial reduced its Edwards Lifesciences (EW) stake by 50% in Q1 2026, selling an estimated $824 and leaving 10 shares worth $826. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Dunhill Financial first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.3K in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Dunhill Financial held 10 shares of Edwards Lifesciences worth $826 as of Q1 2026.
  • Dunhill Financial sold 10 Edwards Lifesciences shares in Q1 2026, an estimated $824.
  • Edwards Lifesciences made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1004 holding.
  • Dunhill Financial first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Edwards Lifesciences position peaked at $11.3K in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.